Celebrity Advertising and Endorsement

March 2nd, 2011

By: Fernando Torres, MSc
The use of popular celebrities in advertising in general is typically an expensive proposition. Its widespread use bears examining from the perspective of the economics of intellectual property; why do firms engage in such large expenses? In our practice, we have kept a close eye on the topic as we consider forming our opinions on rights of publicity litigation, and the economic background of celebrity advertising and endorsement is an interesting one.

Potter to Her Majesty

In Western economies, the practice of associating well known personalities with companies for marketing purposes, to promote brands and products (referred to collectively as “celebrity endorsements”) has a long history spanning the last few centuries. An often quoted pioneer in this practice is the famous eighteen century British potter Josiah Wedgwood, capitalizing on the use of his products by royalty, namely by Queen Charlotte, by describing his business as “Potter to Her Majesty.”

wedgewood

This early use has the same core characteristics as today’s endorsements, such as Natalie Portman’s for Dior perfume.

One in Four

Today, celebrity endorsement is a widespread practice among consumer oriented companies. Research indicates that, at least in the United States, one out of every four marketing programs features some type of celebrity endorser according to Erdogan, Baker, and Tagg, who authored the article “Selecting celebrity endorsers: the practitioner’s perspective” published in the prestigious Journal of Advertising Research (Vol. 41 No. 3, pp. 39-49).

Analytically, it is acknowledged that celebrities are utilized in advertising because they have proven to be much more effective at enhancing a brand’s image and value than other types of advertising such as the use of such archetypical alternatives as:

  • The “professional expert” who would have the perceived authority to recommend a product for its technical merits,
  • The “company manager” that has prototypically dominated furniture and car sales ads in late night television, or
  • The “typical consumer” who recommends a product based on the experience it delivered for him/her.

In the short amount of time a targeted consumer has to notice and consider an advertisement, the immediate recognition of a celebrity is a key attribute for the success of a campaign.  How easily recognizable the celebrity is, and how relevant to the target market demographic of the advertiser are the prime attributes of celebrity endorsements.

One of the most widely known companies using celebrity advertisers is sportswear and equipment supplier Nike®, which typically pays over $500 million annually to a roster of stars which have included Tiger Woods and Michael Jordan. The annual cost of celebrity endorsements represents nearly one-third of Nike’s advertising and promotional expenditures, and according to its SEC filings Nike currently has endorsement contract commitments for $3.8 billion over the next few years.

Cost Effectiveness

The high cost of national advertising campaigns, compounded with the high cost of engaging celebrity participation, raises the question as to how such expenses can be justified, even for well capitalized companies. One answer lies in the direct impact on sales that a celebrity endorsement brings, where higher advertising costs are compensated with higher sales volume. Another rests on the overall positive impact to the companies degree of public awareness and the transfer of goodwill from the endorser to the company’s image. Against the backdrop of the elevated costs of traditional advertising tactics, social media and viral campaigns clearly have signaled a new paradigm in celebrity endorsements, such as the soon-to-be-classic Old Spice YouTube and Twitter interactive campaign using Isaiah Mustafa.

As various researchers have pointed out, it is clear that advertisers generally believe that advertising messages delivered by celebrities provide a higher degree of appeal, attention and possibly message recall than those delivered by non-celebrities, as Menon, Boone, and Rogers, point out in their paper “Celebrity Advertising: An Assessment of its relative effectiveness” (University of Central Arkansas).

In this regard, various studies have established the positive impact of celebrity advertisements on companies’ expected future profits, which lends objective, market-level support to use celebrity endorsers in advertising. The statistical significance of the profit boost gained by companies from such ads has been demonstrated in empirical studies. In essence, publicly traded companies using or announcing endorsements have been shown to experience a boost in their share price performance above what the market and their current financial prospects warrant, i.e. they gain an abnormal market return boost.

Based on a study of 1980-1992 U.S. publicly traded companies announcing contracts with celebrity endorsers record, on average, a gain of 0.44% excess returns in their market value. This empirical study was reported by Agrawal and Kamamkura in the article: “The Economic Worth of Celebrity Endorsers: An event study analysis” published by the Journal of Marketing, (Vol. 59 – July 1995).

Take Away

Therefore, even when expensive, celebrity advertising and endorsements are used by advertisers because they are seen as a profitable investment with immediate and longer-term effects. In our practice we have seen that, when a celebrity’s name or image is used without consent or without paying fair market value, the entity making such unauthorized use is essentially benefiting from free access to the consumers that make-up the celebrity’s fan base.

Author: IPmetrics

Contingent Claims Analysis of Patent Value

March 1st, 2011

In our patent valuation practice, we are constantly seeking to improve the reliability of the analytical methods we apply in valuing intellectual property, particularly the challenging area of patents.

In this post, we’ll be discussing the application of the contingent claims analysis framework to patent valuation, illustrating specific principles and approaches from the field of the financial analysis of stock options.

The basic definition of a financial option in general can be expressed as follows:

The right, but not the obligation, at or before some specified time, to purchase or sell an underlying asset whose price is subject to some form of random variation.

This generalized definition can, and has, been applied to a number of other situations other than financial assets directly. The most common of such non-financial applications of the concept of options is known as “Real Options,” and substantial literature has been built around the application of Option Pricing Theory to the valuation of managerial flexibility, untapped mineral reserves, and the like.

In the field of Intellectual Property, it is notable that there are multiple parallels between the abstract characterization of financial options on stocks and the basic concept of a utility patent. This makes contingent claims analysis attractive theoretically as a way of pricing distinct potentially useful patented products or technologies. Consider the following analogies:

  • Patents and stock options represent a right to exploit an asset in the future, and to exclude others from it.
  • A stock option may be exercised by its owner, or it may be allowed to expire. If it is exercised, the owner of the stock option obtains an equity interest in the underlying firm; thus, gaining exclusive title to a pro-rata share in the stream of dividends.
  • Similarly, a patent gives its owner the right to exclude others from using the underlying invention, and further investment is typically required to exploit its commercial potential.
  • Stock options and patents have a limited timeframe: stock options are valid up to an exercise date, and patents have a statutory expiration date.
  • Both instruments have a direct and precise pricing relationship with an underlying asset: a company in the case of stock options, and an innovation in the case of a patent.
  • Either type of right can be transferred to other parties. A license transfers the right to an invention, and a stock option has organized markets. The price at which the transfer occurs comes at something less than the full value of the underlying asset. The licensee, in the case of patents, will only enter the transaction with the expectation of reaping the difference between the full value of the patent and the license price (paid-up or ongoing royalty).

These parallels have been drawn for some time now and a good reference for an overview of these approaches is R. Pitkethly’s work on The valuation of patents: a review of patent valuation methods with consideration of option based methods and the potential for further research, and M. Reitzig’s Valuing Patents and Patent Portfolios from a Corporate Perspective, both published by the UNECE (Intellectual Assets: Valuation and Capitalization, United Nations, Geneva and New York, 2003).

Prototypical Valuation Model

The best-known approach to the valuation of financial options is the Black-Scholes-Merton model. Although the actual equation utilized in this model is complex, the model can be explained as a rigorous (mathematical) approach to answer two key questions that arise when pricing an option on a stock. Although the market value of a (publicly traded) stock can be ascertained easily by referring to the appropriate organized market, the proper price of the right to buy it at a specified price at some point in the future is not straight forward. Similarly, despite the fact that the profitability of implementing a patented product or process in practice can be achieved with conventional financial tools, the proper valuation of the right to exclude other from doing the same is more complex. The buyer of the (financial) option has to consider two key questions:

  • Given the volatility of the stock price, what is the “likely” range of variation for that price in the future; and
  • What is the proper return on the amount invested with buying the option (even if it expires unexercised).

The option will have value to the buyer only to the extent that the “likely” price in the future exceeds the opportunity cost of earning just as much in a risk-less alternative. The Black-Scholes model gives a precise answer to the term “likely,” by applying the statistical model of the Normal distribution to the variations of the stock price. This summarizes the volatility of stock prices in a single number, or parameter, called the variance. On the other hand, the amount invested in the future to exercise the option should provide revenue comparable, at a minimum, to a suitable risk-free rate of return, conventionally the yield on certain government bonds.

patent

For stock options, their value is the current stock price multiplied by a probability minus the present value of the exercise price multiplied by another probability. Within this framework, the option price (maximum expected profit) stands for the value of the patent. In effect, a patent is valuable today to the extent the probability-adjusted potential net income from practicing (or licensing) it exceeds the probability-adjusted additional expense of maintaining its validity and developing the ancillary assets required to implement it.

The application of this approach requires consideration of the applicability of the option-patent parallel, and due attention to the actual negotiated context in which the patent licensing transaction is deemed to take place, the commercialization commitments of the parties, and other factors of the dilution of the value of the patent. Applying many of the observations and assumptions introduced for this purpose by Frank R.F. Russell Denton and Paul J. Heald in: “Random Walks, non-cooperative games, and the complex mathematics of patent valuation” 55, Rutgers Law Review, 1175-1288 (2003).

Expressed as a proportion of the anticipated profits from the patent protection, the price of the option in this method, divided by the net present value of the patent’s addressable revenue is directly interpreted as the optimal royalty rate attributable to the patent.

____________

Additional material based on this approach, with examples and additional tools will be developed in future posts and in IPmetrics’ Patent Value Guide.